Markets:
DJIA --339.820.96%
NASDAQ --166.64-1.15%
S&P --44.340.97%
Featured Stocks:
SOFI +13.68% 13.71
BIIB -1.28% 230.81
MU -3.09% 90.00
EVGO +1.21% 8.34
Category

Stocks to Buy Article

Trading Strategies

How to Profit from a $16.2 Billion Luxury Loser

By , Special Contributor, Money Morning - • Print | Email

Well, it was fun while it lasted.

For a few weeks now, the market has been buzzing about the "inevitable" acquisition of luxury brand Tiffany & Co. by Bernard Arnault's luxury juggernaut LVMH Moet Hennessy Louis Vuitton SE.

To hear the media talk about it, it was a done deal – a dead certainty. Nothing could stop it. The $16.2 billion deal would have been the biggest acquisition in the high-flying luxury sector's history.

Of course I say "would have," because it all just fell apart. The sound of corporate wedding bells has been replaced by the shouts of corporate lawyers.

But if you make this easy move, you'll hear the sweet sound of a ringing cash register… Full Story

But if you make this easy move, you'll hear the sweet sound of a ringing cash register...

ETFs

Why Your Next Big Profit Opportunity Is Companies Getting Smaller

By , Defense + Tech Specialist, Money Morning • @Robinson_STI - • Print | Email

Joseph Papa, the CEO of Bausch Health Cos. Inc., was hired in 2016 to help turn the pharmaceutical company around.

Instead, he is breaking it up. But he's not crazy.

He's caught on to the fact that bigger isn't always better.

You see, Bausch Health and its subsidiary, Bausch + Lomb eye care, are two great companies… but together, they aren't exactly chocolate and peanut butter.

Papa has realized that the only thing worse than no partnership at all is a bad partnership. So he's letting Bausch + Lomb become its own $3.1 billion business.

This means that both companies will be free to focus on their own business models, their own specialized products, and their own target markets.

It's a move that's going to create billions in new shareholder value.

And while I applaud the move, I think that there's an even better way to cash in on corporate spinoffs like this one.

That's because Joseph Papa's move is part of a massive trend that will be extremely profitable for investors… Full Story

That's because Joseph Papa's move is part of a massive trend that will be extremely profitable for investors...

Election

The Best Stocks to Buy If Biden Wins the Election

By , Associate Editor, Money Morning • @DavidGZeiler - • Print | Email

As an investor, it's important to cast a cold eye on the presidential election.

You need to scope out the best stocks to buy no matter who wins.

Right now former vice president Joe Biden is leading in the polls, so investors need to have a plan for a Biden victory.

We've outlined just how a Biden win would affect your money.

And we have three top stocks to buy from our new chief investment strategist...

Trading Strategies

How to Build a Bulletproof Buy List

By , Chief Investment Strategist, Money Map Report - • Print | Email

This week, over the span of just 24 hours, we saw a market rally of nearly 1,170 points followed by a sharp decline of 900.

The market moved back and forth a total of 3,253 points in just the first three days of the week. Treasury yields sank to record lows as these wild swings continued.

And you better hang on to your hats because this market whipsawing isn't going anywhere anytime soon.

Now, if you were following along last week, I told you to make sure you keep those trailing stops nice and tight. I do realize that some of you are all stopped out and wondering, "What's next?"

Or, more specifically, "Is it time to buy?" and "What do I buy?"

While I believe that most stocks are a bit too risky and volatile to buy right now, I am getting my wish list ready. It's growing by the minute.

With so many stocks "on sale" right now, there are six criteria I'm starting with to find my next best buys… Full Story

With so many stocks "on sale" right now, there are six criteria I'm starting with to find my next best buys... Full Story

Earnings

The 3 Stocks to Buy Before Earnings Season to Boost Your Portfolio

By , Quantitative Specialist, Money Morning - • Print | Email

This week, we're going to see hundreds of companies announce their quarterly results.

We've already seen some interesting trends in how the market has reacted to earnings reports already.

That's creating an opportunity for traders who know where to look.

I'll show you three stocks to buy before earnings reports come out that will maximize your upside potential.

Read more...

Stocks

The 3 Best Sectors to Invest in for 2020 (with Stock Picks for Each)

By , Money Morning - • Print | Email

Stocks rallied 29% in 2019.

It was such as strong year, some pundits think 2020 would be a likely time for the longest bull run in stock market history to pull back.

Not the case.

The truth is, a year following a 20% or more gain is statistically pretty good, too.

That's why it's time to show you the best sectors to invest in 2020.

Focusing on these could potentially give you the biggest chance at year's profit potential.

Read more...

Stocks

Our Proprietary System Just Gave These 5 Stocks “Top Grades” for 2020

By , Guest Writer, Money Morning - • Print | Email

2019 has been an outstanding year for the markets.

Through Dec. 20, the S&P 500 climbed an incredible 27% year to date.

In the same time frame, The Dow jumped 22%, and the Nasdaq popped an incredible 33%.

A blind squirrel could have found success in the market this year.

Throw a dart, and 20% returns were in the bag.

Unfortunately, it won’t be that easy in 2020.

But with the help of our proprietary stock ranking system, we were able to pinpoint five stocks with absolute breakout potential…

Stocks

This Mission-Critical Aerospace Stock Could Hand You a 135% Gain

By , Associate Editor, Money Morning - • Print | Email

The Fortune 500, NASA, and the Armed Forces all depend on one aerospace stock.

And thanks a market overreaction, you can get it now at a steep discount.

Find out why this pick could give you a 150% gain – or more.

Read more...

Stocks

All Signs Point to 200% Gains - or More - for This Stock to Buy

By , Associate Editor, Money Morning - • Print | Email

Wall Street has written off this stock over the last few years.

But that mistake is your gain.

Find out why this stock to buy could soar 200% or more.

Read more...

GlaxoSmithKline Is Now a Top Pharmaceutical Stock to Buy

By , Associate Editor, Money Morning • @DavidGZeiler - • Print | Email

GlaxoSmithKline doesn't appear to be a top pharmaceutical stock to buy – at least not at first glance.

Its shares have underperformed the global pharma sector by 60% over the past decade.

But since Glaxo got a new CEO in 2017, the company has been on the path to a leaner, more focused company.

And with a high Money Morning Stock VQScore™, GSK is looking very attractive indeed.